Interstitial Lung Disease

Update on the Evaluation and Management of Interstitial Lung Abnormalities
New guidelines outline the screening and follow-up procedures for ILAs as well as define who is at higher risk for progressing to ILD.

The Impact of Short Telomere Syndrome on Lung Transplantation
STS can increase post-lung transplant complications, necessitating tailored pretransplant and posttransplant assessments and multidisciplinary care.

Delving Deeper Into the Molecular Genetics of Idiopathic Pulmonary Fibrosis
William Whalen II, MD, MS, reflects on his experience as a recipient of the 2023 CHEST Research Grant in Pulmonary Fibrosis and how it has affected his professional trajectory.

Navigating New ACR/CHEST Guidelines for Screening, Monitoring, and Treatment of SARD-ILD
Experts discuss early screening with high-resolution chest tomography, cautious glucocorticoid use, and personalized steroid-sparing treatment.

Incorporating Climate-Related Events Into Clinical Practice
Review six steps a pulmonary clinician can take prior to a climate-related event to prepare for a potential disaster scenario and mitigate patient risk.

GOLDen Handcuffs: Beyond Spirometry in COPD
When it comes to diagnosing COPD, clinicians must look beyond spirometry and physiology to see a patient fully.

Admilparant Phase 2 Results Raise Hopes for Combination Treatment in Pulmonary Fibrosis
Fernando Martinez, MD, FCCP, said he expects the treatment options for fibrotic lung disease will soon become more complex—in a good way—as more effective therapies become available.

Top-Line Results From FIBRONEER-ILD Point to Possible Third Agent for ILD
If the data prove accurate, Barry Shea, MD, said nerandomilast could become the first new treatment for lung fibrosis in more than a decade.